首页 | 本学科首页   官方微博 | 高级检索  
     


Pharmacokinetics of 2-methyl-9-hydroxyellipticinium acetate (NSC-264137) in cancer patients (phase I study)
Affiliation:1. Laboratoire de Chimiothérapie expérimentale (LA 147 CNRS & U 140 INSERM), 94800 Villejuif, France;2. Département de Statistiques, Institut Gustave-Roussy, 39 à 53, Rue Camille-Desmoulins, 94800 Villejuif, France;3. Département de Médecine Adulte, Institut Gustave-Roussy, 39 à 53, Rue Camille-Desmoulins, 94800 Villejuif, France;1. State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China;2. Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin 300457, China;3. College of Basic Sciences, Tianjin Agricultural University, 22 Jinjing Road, Xiqing District, Tianjin 300392, China;4. Department of Oramaxillofacial - Head and Neck Surgery, Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin 300041, China;1. Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu 610041, China;2. Department of Colorectal Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu 610041, China;1. Department of Radiation Oncology, Huai’an Hospital Affiliated to Xuzhou Medical University, Huaian, 223001, China;2. Department of Oncology, Huai’an Hospital Affiliated to Xuzhou Medical University, Huaian, 223001, China
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号